Halozyme Therapeutics Inc (HALO)
Halozyme - HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
Maravai LifeSciences Holdings LLC (MRVI)
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
SEZZLE INC. (SEZL)
Sezzle Reports Second Quarter 2026 Results
AKAMAI TECHNOLOGIES INC (AKAM)
Akamai Reports Second Quarter 2026 Financial Results
NEXTCURE, INC. (NXTC)
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
XENON PHARMACEUTICALS INC. (XENE)
Xenon Reports Q2 2026 Financial Results and Provides Business Update
AMERICAN COASTAL INSURANCE CORP (ACIC)
American Coastal Insurance Corporation Announces an Additional $25 Million of Stock Repurchase Authorization
VOYAGER THERAPEUTICS, INC. (VYGR)
Voyager Reports Second Quarter 2026 Financial and Operating Results
IN8BIO, INC. (INAB)
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
CELLDEX THERAPEUTICS, INC. (CLDX)
Celldex Reports Second Quarter Financial Results and Provides Corporate Update
NEWAMSTERDAM PHARMA CO N.V. (NAMS)
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OUTSET MEDICAL, INC. (OM)
Outset Medical Reports Second Quarter 2026 Results
RESEARCH FRONTIERS INC (REFR)
Research Frontiers Reports Second Quarter 2026 Financial Results and Will Host a Conference Call at 4:30 p.m. Today
DEFINIUM THERAPEUTICS, INC. (DFTX)
Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
VTEX (VTEX)
VTEX Reports Second Quarter 2026 Financial Results